ReviewJournal of translational medicine2022
Natural killer cells: a promising immunotherapy for cancer.
Junfeng Chu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
109 papers cite itlatest 60 shown
this paperpooled ittrialcites it